Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...

Amgen (AMGN) is getting closer to challenging the weight-loss drug duopoly of Novo Nordisk (NVO), the maker of Ozempic and Wegovy, and Eli Lilly (LLY), which produces Zepbound.